Jane N. Winter

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou, Laurie H. Sehn, Alfred Rademaker et al. · Blood · 2013 · 934 citations · Full text

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

Kenneth R. Carson, Andrew M. Evens, Elizabeth Richey et al. · Blood · 2009 · 866 citations · Full text

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Philippe Armand, Arnon Nagler, Edie Weller et al. · Journal of Clinical Oncology · 2013 · 437 citations · Full text

ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma

Ralph M. Meyer, Mary Gospodarowicz, Joseph M. Connors et al. · New England Journal of Medicine · 2011 · 404 citations · Full text

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

Nancy L. Bartlett, Wyndham H. Wilson, Sin‐Ho Jung et al. · Journal of Clinical Oncology · 2019 · 395 citations